Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuru Shinohara

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Nature Communications|July 4, 2019
Author Correction: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease modelLi Zhong, Ying Xu, Rengong Zhuo, et al.
Urologic Oncology|January 24, 2017
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladderTohru Nakagawa, Satoru Taguchi, Yukari Uemura, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 2016
ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal PathologyNobutaka Sakae, Chia-Chen Liu, Mitsuru Shinohara, et al.
Nature Communications|October 24, 2018
APOE ε2 is associated with increased tau pathology in primary tauopathyNa Zhao, Chia-Chen Liu, Alexandra J Van Ingelgom, et al.
Cancer|June 24, 2020
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trialKazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, et al.
Cancer Medicine|May 1, 2021
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo, Hirofumi Koga, Kazuto Ito, et al.
Nature Neuroscience|March 22, 2016
C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteinsYong-Jie Zhang, Tania F Gendron, Jonathan C Grima, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Nature Communications|July 4, 2019
Author Correction: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease modelLi Zhong, Ying Xu, Rengong Zhuo, et al.
Urologic Oncology|January 24, 2017
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladderTohru Nakagawa, Satoru Taguchi, Yukari Uemura, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 2016
ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal PathologyNobutaka Sakae, Chia-Chen Liu, Mitsuru Shinohara, et al.
Nature Communications|October 24, 2018
APOE ε2 is associated with increased tau pathology in primary tauopathyNa Zhao, Chia-Chen Liu, Alexandra J Van Ingelgom, et al.
Cancer|June 24, 2020
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trialKazuto Ito, Mikio Kobayashi, Motokiyo Komiyama, et al.
Cancer Medicine|May 1, 2021
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo, Hirofumi Koga, Kazuto Ito, et al.
Nature Neuroscience|March 22, 2016
C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteinsYong-Jie Zhang, Tania F Gendron, Jonathan C Grima, et al.
Pageof 7